Literature DB >> 18999353

Rats and humans paying attention: cross-species task development for translational research.

Elise Demeter1, Martin Sarter, Cindy Lustig.   

Abstract

Substantial gains have been made on the neurobiology of attention from systems neuroscience work in animal models and human cognitive neuroscience. However, the integration of rodent-based research on the specific neurotransmitter systems that subserve attention with the results from human behavioral and neuroimaging studies has been hampered by the lack of tasks that validly assess attention in both species. To address this issue, an operant sustained attention task that has been extensively used in research on the neurobiology of attention in rats was redesigned and validated for use in humans. Although humans showed better performance overall, the two species showed similar effects of several attention-related variables, including the introduction of distractor-related challenge. This task provides a useful tool for integrative, cross-species research and may help to determine how specific neurotransmitter systems contribute to the hemodynamic changes observed in human functional neuroimaging experiments.

Entities:  

Mesh:

Year:  2008        PMID: 18999353      PMCID: PMC2705465          DOI: 10.1037/a0013712

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  45 in total

1.  Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation.

Authors:  T M Gill; M Sarter; B Givens
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

2.  Neuroimaging studies of shifting attention: a meta-analysis.

Authors:  Tor D Wager; John Jonides; Susan Reading
Journal:  Neuroimage       Date:  2004-08       Impact factor: 6.556

3.  Cross-dimensional perceptual selectivity.

Authors:  J Theeuwes
Journal:  Percept Psychophys       Date:  1991-08

4.  Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats.

Authors:  J Turchi; M Sarter
Journal:  Brain Res Cogn Brain Res       Date:  1997-10

5.  Interaction of signal discriminability and task type in vigilance decrement.

Authors:  R Parasuraman; M Mouloua
Journal:  Percept Psychophys       Date:  1987-01

Review 6.  Preclinical research into cognition enhancers.

Authors:  Martin Sarter
Journal:  Trends Pharmacol Sci       Date:  2006-09-25       Impact factor: 14.819

7.  Augmented prefrontal acetylcholine release during challenged attentional performance.

Authors:  Rouba Kozak; John P Bruno; Martin Sarter
Journal:  Cereb Cortex       Date:  2005-03-23       Impact factor: 5.357

Review 8.  Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection.

Authors:  Martin Sarter; Michael E Hasselmo; John P Bruno; Ben Givens
Journal:  Brain Res Brain Res Rev       Date:  2005-02

9.  Prefrontal acetylcholine release controls cue detection on multiple timescales.

Authors:  Vinay Parikh; Rouba Kozak; Vicente Martinez; Martin Sarter
Journal:  Neuron       Date:  2007-10-04       Impact factor: 17.173

10.  Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands.

Authors:  J McGaughy; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

View more
  61 in total

1.  Bidirectional interactions between circadian entrainment and cognitive performance.

Authors:  Howard J Gritton; Ana Kantorowski; Martin Sarter; Theresa M Lee
Journal:  Learn Mem       Date:  2012-03-01       Impact factor: 2.460

Review 2.  CNTRICS final animal model task selection: control of attention.

Authors:  C Lustig; R Kozak; M Sarter; J W Young; T W Robbins
Journal:  Neurosci Biobehav Rev       Date:  2012-06-06       Impact factor: 8.989

Review 3.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

4.  Monitoring cholinergic activity during attentional performance in mice heterozygous for the choline transporter: a model of cholinergic capacity limits.

Authors:  Giovanna Paolone; Caitlin S Mallory; Ajeesh Koshy Cherian; Thomas R Miller; Randy D Blakely; Martin Sarter
Journal:  Neuropharmacology       Date:  2013-08-16       Impact factor: 5.250

Review 5.  What do phasic cholinergic signals do?

Authors:  Martin Sarter; Cindy Lustig; Anne S Berry; Howard Gritton; William M Howe; Vinay Parikh
Journal:  Neurobiol Learn Mem       Date:  2016-02-18       Impact factor: 2.877

6.  Cholinergic control over attention in rats prone to attribute incentive salience to reward cues.

Authors:  Giovanna Paolone; Christopher C Angelakos; Paul J Meyer; Terry E Robinson; Martin Sarter
Journal:  J Neurosci       Date:  2013-05-08       Impact factor: 6.167

7.  Sustained attention in mice: expanding the translational utility of the SAT by incorporating the Michigan Controlled Access Response Port (MICARP).

Authors:  Megan St Peters; Ajeesh Koshy Cherian; Marc Bradshaw; Martin Sarter
Journal:  Behav Brain Res       Date:  2011-08-22       Impact factor: 3.332

Review 8.  Cholinergic double duty: cue detection and attentional control.

Authors:  Martin Sarter; Cindy Lustig
Journal:  Curr Opin Psychol       Date:  2019-01-04

Review 9.  Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.

Authors:  Martin Sarter; Roger L Albin; Aaron Kucinski; Cindy Lustig
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

10.  Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging.

Authors:  Vinay Parikh; William M Howe; Ryan M Welchko; Sean X Naughton; Drew E D'Amore; Daniel H Han; Monika Deo; David L Turner; Martin Sarter
Journal:  Eur J Neurosci       Date:  2012-12-11       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.